Emerging Immunohistochemical Biomarkers for Myeloid Neoplasms.
Context.--Pathologists can greatly improve patient care and advance the understanding of disease progression by adeptly employing relevant biomarkers when diagnosing myeloid neoplasms. Although the molecular era has ushered in countless molecular biomarkers in this field, the necessary techniques ca...
| Publicado en: | Archives of Pathology & Laboratory Medicine Vol. 147; no. 4; pp. 403 - 413 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
College of American Pathologists
Apr2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |